Bafadhel, M., Sing, D., Jenkins, C., Peterson, S., Bengtsson, T., & Fageras, M. (2018). Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS). European Respiratory Society.
Cita Chicago Style (17a ed.)Bafadhel, M., D. Sing, C. Jenkins, S. Peterson, T. Bengtsson, y M. Fageras. Late Breaking Abstract - Protection by Budesonide Against Clinically Important Deteriorations (CID) in Patients with COPD Is Dependent on Blood Eosinophil Counts (EOS). European Respiratory Society, 2018.
Cita MLA (9a ed.)Bafadhel, M., et al. Late Breaking Abstract - Protection by Budesonide Against Clinically Important Deteriorations (CID) in Patients with COPD Is Dependent on Blood Eosinophil Counts (EOS). European Respiratory Society, 2018.